寡转移性前列腺癌:荷兰多学科共识会议结果
荷兰多学科专家小组采用改良德尔菲法,对34名代表就寡转移性前列腺癌的生物学、治疗目标和管理进行共识投票,56%的陈述达成共识。小组认为寡转移性前列腺癌是激素敏感状态下转移灶数量有限(3至5个转移灶、最多2个器官)的疾病状态,PSMA PET/CT目前被认为是最准确的诊断影像方法,针对所有转移灶的靶向治疗将延缓疾病进一步播散,但具体治疗方案意见分歧。
要点
- 共识将寡转移性前列腺癌定义为激素敏感状态下转移灶数量有限,累及3至5个转移灶、最多2个器官。
- 小组认为PSMA PET/CT目前是最准确的诊断影像方法。
- 小组共识认为针对所有转移灶的靶向治疗将延缓疾病进一步播散,但具体治疗方案意见分歧。
核心结论
- 多学科小组达成共识,认为寡转移性前列腺癌是需要个体化治疗的特定疾病状态,应开展登记和临床研究关注生物学与临床参数以优化同步性和异时性寡转移性前列腺癌的治疗策略。
研究设计与样本
- 改良德尔菲法,包括探索性调查和共识会议,专家小组由34名荷兰泌尿外科、肿瘤内科和放射肿瘤科、放射科、核医学科及基础研究代表组成,共识定义为≥75%的小组同意。
诊断标准与关键数值
- 共识定义为≥75%的小组对陈述达成一致。
- 小组认为寡转移性前列腺癌包括激素敏感状态下转移灶数量有限,同步性和异时性表现均包括在内。
- 小组认为转移灶数量有限涉及3至5个转移灶、最多2个器官。
- 小组认为PSMA PET/CT目前是最准确的诊断影像方法。
- 56%的陈述达成共识。
临床应用与阅片要点
- 小组共识认为针对寡转移性前列腺癌所有转移灶的靶向治疗将延缓疾病进一步播散。
- 小组对具体治疗方案意见分歧。
- 作者建议寡转移性前列腺癌登记和临床研究应关注生物学和临床参数,以优化同步性和异时性寡转移性前列腺癌的治疗策略。
局限性
- 小组结果受限于寡转移性前列腺癌缺乏科学证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Oligometastatic prostate cancer (OMPC) is a heterogeneous disease state that is imperfectly understood, and its clinical implications are unclear.
OBJECTIVE: To determine the consensus of a Dutch multidisciplinary expert panel on biological aspects, treatment goals, and management of OMPC in daily clinical practice.
DESIGN, SETTING, AND PARTICIPANTS: The study comprised a modified Delphi method including an explorative survey with various statements and questions, followed by a consensus meeting to discuss and determine the agreement with revised statements and related items. The panel consisted of 34 Dutch representatives from urology, medical and radiation oncology, radiology, nuclear medicine, and basic research.
OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Agreement was determined with statements (five-point scale). Consensus was defined as ≥75% panel agreement with a statement.
RESULTS AND LIMITATIONS: Consensus existed for 56% of statements. The panel agreed that OMPC comprises a limited metastatic spread in the hormone-sensitive setting, in both the synchronous and the metachronous presentation. Limited metastatic spread was believed to involve three to five metastases and a maximum of two organs. Prostate-specific membrane antigen positron emission tomography/computed tomography scan was currently perceived as the most accurate diagnostic imaging modality. Although there was a consensus that targeted treatment of all metastases in OMPC will delay further dissemination of the disease, opinions on specific treatment regimens were divided. Panel outcomes were limited by the lack of scientific evidence on OMPC.
CONCLUSIONS: A multidisciplinary panel reached a consensus that OMPC is a specific disease state requiring a tailored treatment approach. OMPC registries and clinical studies should focus on both the biology and the clinical parameters in relation to optimal treatment strategies in synchronous and metachronous OMPC.
PATIENT SUMMARY: A group of Dutch medical specialists agreed that prostate cancer patients having few metastases may benefit from a new therapeutic approach. Clinical studies need to determine which treatment is best for each specific situation.
引用
- Aluwini SS, Mehra N, Lolkema MP, et al. Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting. Eur Urol Oncol. 2019. PMID: 31401014. doi:10.1016/j.euo.2019.07.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。